Geniposide attenuates postischemic long-term potentiation via GluN2A

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• N-Methyl-D-aspartate receptor (NMDAR)-mediated oxidative stress contributes to neuronal damage after ischemic stroke.
• Geniposide has shown neuroprotective effects in vivo, but its role in vitro during ischemic conditions is unclear.

Purpose of the Study:

• To investigate whether geniposide ameliorates injury to hippocampal neurons during in vitro ischemic Long Term Potentiation (iLTP) induction.
• To elucidate the role of specific NMDAR subunits in geniposide's neuroprotective effects.

Main Methods:

• Hippocampal neurons were subjected to oxygen-glucose deprivation or hydrogen peroxide insult.
• Cell viability was assessed using MTT assay.
• Electrophysiological recordings measured field excitatory postsynaptic potentials (fEPSPs) to evaluate iLTP.
• Specific NMDAR antagonists (GluN2A and GluN2B) were used to determine receptor involvement.

Main Results:

• Geniposide treatment attenuated neuronal apoptosis and oxidative stress.
• Medium and high doses of geniposide improved iLTP, indicating enhanced synaptic function.
• The protective effects of geniposide were abolished by a GluN2A antagonist but not by a GluN2B inhibitor.

Conclusions:

• Geniposide demonstrates neuroprotective effects against ischemic injury in vitro in a dose-dependent manner.
• These findings suggest that geniposide attenuates postischemic LTP induction.
• GluN2A-containing NMDARs are critically involved in the neuroprotection afforded by geniposide during ischemia.